EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Inflammatory Bowel Diseases and Gut Microbiota

Yuri Haneishi iD, Yuma Furuya, Mayu Hasegawa, Antonio Picarelli, Mauro Rossi iD, Junki Miyamoto

International Journal of Molecular Sciences · 14.02.2023 · 24 (4) · 3817

DOI: 10.3390/ijms24043817 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 14.02.2023. Verfasst von Yuri Haneishi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Applied Biological Science, Graduate School of Agriculture, Tokyo University of Agriculture and Technology, Fuchu-shi 183-8509, Tokyo, …. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Inflammatory Bowel Diseases, Microbiota, Probiotics. Die Arbeit wurde bisher 248-mal zitiert (Crossref) und nennt 107 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, the Uehara Memorial Foundation, the Lotte Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inflammatory bowel disease (IBD) is an inflammatory disease of the gastrointestinal tract, the incidence of which has rapidly increased worldwide, especially in developing and Western countries. Recent research has suggested that genetic factors, the environment, microbiota, and immune responses are involved in the pathogenesis; however, the underlying causes of IBD are unclear. Recently, gut microbiota dysbiosis, especially a decrease in the abundance and diversity of specific genera, has been suggested as a trigger for IBD-initiating events. Improving the gut microbiota and identifying the specific bacterial species in IBD are essential for understanding the pathogenesis and treatment of IBD and autoimmune diseases. Here, we review the different aspects of the role played by gut microbiota in the pathogenesis of IBD and provide a theoretical basis for modulating gut microbiota through probiotics, fecal microbiota transplantation, and microbial metabolites.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeInflammatory Bowel DiseasesMicrobiotaProbioticsHumansBacteriaFecal Microbiota TransplantationDysbiosis

Stichwörter der Autor:innen

fecal microbiota transplantationgut microbiotaimmunityinflammationinflammatory bowel diseaseprobiotics

Autor:innen und Institutionen

  • Department of Applied Biological Science, Graduate School of Agriculture, Tokyo University of Agriculture and Technology, Fuchu-shi 183-8509, Tokyo, Japan.
  • Department of Translational and Precision Medicine, Sapienza University of Rome, 00185 Rome, Italy.
  • Institute of Food Sciences, National Research Council (CNR), Via Roma 64, 83100 Avellino, Italy.

ORCID-Profile: Yuri Haneishi, Mauro Rossi

Förderung

  • Japan Society for the Promotion of Science
  • the Uehara Memorial Foundation
  • the Lotte Foundation
  • the Astellas Foundation for Research on Metabolic Disorders
  • the Asahi Glass Foundation
  • JSPS KAKENHI
  • Uehara Memorial Foundation
  • Lotte Foundation

Zitieren

APA

Haneishi, Y., Furuya, Y., Hasegawa, M., Picarelli, A., Rossi, M., & Miyamoto, J. (2023). Inflammatory Bowel Diseases and Gut Microbiota. International Journal of Molecular Sciences, 24(4), 3817. https://doi.org/10.3390/ijms24043817

Vancouver

Haneishi Y, Furuya Y, Hasegawa M, Picarelli A, Rossi M, Miyamoto J. Inflammatory Bowel Diseases and Gut Microbiota. International Journal of Molecular Sciences. 2023;24(4):3817. doi:10.3390/ijms24043817

BibTeX
@article{Haneishi2023,
  author = {Haneishi, Yuri and Furuya, Yuma and Hasegawa, Mayu and Picarelli, Antonio and Rossi, Mauro and Miyamoto, Junki},
  title = {Inflammatory Bowel Diseases and Gut Microbiota},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {4},
  pages = {3817},
  doi = {10.3390/ijms24043817}
}
Kostenlos starten →